Functional Alterations in Memory Networks in Early Alzheimer’s Disease
详细信息 查看全文
- 作者：Reisa A. Sperling (1) (2) (4) (5)
Bradford C. Dickerson (2) (4) (5)
Maija Pihlajamaki (1) (5)
Patrizia Vannini (1) (4) (5)
Peter S. LaViolette (1) (4)
Ottavio V. Vitolo (1) (5)
Trey Hedden (3) (4)
J. Alex Becker (3)
Dorene M. Rentz (1) (5)
Dennis J. Selkoe (1) (5)
Keith A. Johnson (1) (3) (5) - 关键词：Functional magnetic resonance imaging ; Amyloid ; PiB ; Alzheimer’s disease ; Aging ; Hippocampus ; Default network
- 刊名：NeuroMolecular Medicine
- 出版年：2010
- 出版时间：March 2010
- 年：2010
- 卷：12
- 期：1
- 页码：27-43
- 全文大小：663KB
- 参考文献：1. Alexander, G. E., Chen, K., Pietrini, P., Rapoport, S. I., & Reiman, E. M. (2002). Longitudinal PET evaluation of cerebral metabolic decline in dementia: A potential outcome measure in Alzheimer’s disease treatment studies. / American Journal of Psychiatry, / 159, 738-45.
2. Alpar, A., Ueberham, U., Bruckner, M. K., Seeger, G., Arendt, T., & Gartner, U. (2006). Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice. / Brain Research, / 1099(1), 189-98.
3. Amieva, H., Le Goff, M., Millet, X., Orgogozo, J. M., Peres, K., Barberger-Gateau, P., et al. (2008). Prodromal Alzheimer’s disease: Successive emergence of the clinical symptoms. / Annals of Neurology, / 64, 492-98.
4. Andrews-Hanna, J. R., Snyder, A. Z., Vincent, J. L., Lustig, C., Head, D., Raichle, M. E., et al. (2007). Disruption of large-scale brain systems in advanced aging. / Neuron, / 56, 924-35.
5. Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991). The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. / Cerebral Cortex, / 1, 103-16.
6. Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992a). Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. / Neurology, / 42, 631-39.
7. Arriagada, P. V., Marzloff, K., & Hyman, B. T. (1992b). Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer’s disease. / Neurology, / 42, 1681-688.
8. Bacskai, B. J., Frosch, M. P., Freeman, S. H., Raymond, S. B., Augustinack, J. C., Johnson, K. A., et al. (2007). Molecular imaging with Pittsburgh compound B confirmed at autopsy: A case report. / Archives of Neurology, / 64, 431-34.
9. Bai, F., Zhang, Z., Yu, H., Shi, Y., Yuan, Y., Zhu, W., et al. (2008). Default-mode network activity distinguishes amnestic type mild cognitive impairment from healthy aging: A combined structural and resting-state functional MRI study. / Neuroscience Letters, / 438, 111-15.
10. Baig, S., Wilcock, G. K., & Love, S. (2005). Loss of perineuronal net N-acetylgalactosamine in Alzheimer’s disease. / Acta Neuropathologica, / 110, 393-01.
11. Bakkour, A., Morris, J. C., & Dickerson, B. C. (2008). The cortical signature of prodromal AD. Regional thinning predicts mild AD dementia. / Neurology, / 72, 1048-055.
12. Bassett, S. S., Yousem, D. M., Cristinzio, C., Kusevic, I., Yassa, M. A., Caffo, B. S., et al. (2006). Familial risk for Alzheimer’s disease alters fMRI activation patterns. / Brain, / 129, 1229-239.
13. Bennett, D., Schneider, J., Arvanitakis, Z., Kelly, J., Aggarwal, N., Shah, R., et al. (2006). Neuropathology of older persons without cognitive impairment from two community-based studies. / Neurology, / 66, 1837-844.
14. Biswal, B., Yetkin, F. Z., Haughton, V. M., & Hyde, J. S. (1995). Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. / Magnetic Resonance in Medicine, / 34, 537-41.
15. Black, R., Sperling, R., Kirby, L., Safirstein, B., Motter, R., Pallay, A., et al. (2010) A single-ascending dose study of bapineuzumab (AAB-001), a humanized monoclonal antibody to A-beta, in AD. / Alzheimer’s Disease and Associated Disorders (e-pub).
16. Bondi, M. W., Houston, W. S., Eyler, L. T., & Brown, G. G. (2005). fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. / Neurology, / 64, 501-08.
17. Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., et al. (2000). Patterns of brain activation in people at risk for Alzheimer’s disease. / New England Journal of Medicine, / 343, 450-56.
18. Borghesani, P. R., Johnson, L. C., Shelton, A. L., Peskind, E. R., Aylward, E. H., Schellenberg, G. D., et al. (2007). Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers. / Neurobiology of Aging, / 29, 981-91.
19. Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. / Acta Neuropathol (Berl), / 82, 239-59.
20. Brewer, J. B., Zhao, Z., Desmond, J. E., Glover, G. H., & Gabrieli, J. D. (1998). Making memories: Brain activity that predicts how well visual experience will be remembered. / Science, / 281, 1185-187.
21. Buckner, R. L. (2004). Memory and executive function in aging and AD: Multiple factors that cause decline and reserve factors that compensate. / Neuron, / 44, 195-08.
22. Buckner, R. L., Andrews-Hanna, J. R., & Schacter, D. L. (2008). The brain’s default network: Anatomy, function, and relevance to disease. / Annals of the New York Academy of Sciences, / 1124, 1-8.
23. Buckner, R. L., Sepulcre, J., Talukdar, T., Krienen, F. M., Liu, H., Hedden, T., et al. (2009). Cortical hubs revealed by intrinsic functional connectivity: Mapping, assessment of stability, and relation to Alzheimer’s disease. / Journal of Neuroscience, / 29, 1860-873.
24. Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., et al. (2005). Molecular, structural, and functional characterization of Alzheimer’s disease: Evidence for a relationship between default activity, amyloid, and memory. / Journal of Neuroscience, / 25, 7709-717.
25. Busche, M. A., Eichhoff, G., Adelsberger, H., Abramowski, D., Wiederhold, K. H., Haass, C., et al. (2008). Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer’s disease. / Science, / 321, 1686-689.
26. Celone, K. A., Calhoun, V. D., Dickerson, B. C., Atri, A., Chua, E. F., Miller, S. L., et al. (2006). Alterations in memory networks in mild cognitive impairment and Alzheimer’s disease: An independent component analysis. / Journal of Neuroscience, / 26, 10222-0231.
27. Chetelat, G., Landeau, B., Eustache, F., Mezenge, F., Viader, F., de la Sayette, V., et al. (2005). Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study. / Neuroimage, / 27, 934-46.
28. Chua, E. F., Schacter, D. L., Rand-Giovannetti, E., & Sperling, R. A. (2006). Understanding metamemory: Neural correlates of the cognitive process and subjective level of confidence in recognition memory. / Neuroimage, / 29, 1150-160.
29. Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., et al. (2005). Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. / Neuron, / 48, 913-22.
30. Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., et al. (2005). Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. / Nature Neuroscience, / 8, 79-4.
31. Clement, F., & Belleville, S. (2009). Test-retest reliability of fMRI verbal episodic memory paradigms in healthy older adults and in persons with mild cognitive impairment. / Human Brain Mapping, / 30, 4033-047.
32. Cohen, E. R., Ugurbil, K., & Kim, S. G. (2002). Effect of basal conditions on the magnitude and dynamics of the blood oxygenation level-dependent fMRI response. / Journal of Cerebral Blood Flow and Metabolism, / 22, 1042-053.
33. Coleman, P., Federoff, H., & Kurlan, R. (2004). A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. / Neurology, / 63, 1155-162.
34. D’Amore, J. D., Kajdasz, S. T., McLellan, M. E., Bacskai, B. J., Stern, E. A., & Hyman, B. T. (2003). In vivo multiphoton imaging of a transgenic mouse model of Alzheimer disease reveals marked thioflavine-S-associated alterations in neurite trajectories. / Journal of Neuropathology and Experimental Neurology, / 62, 137-45.
35. D’Esposito, M., Zarahn, E., Aguirre, G. K., & Rypma, B. (1999). The effect of normal aging on the coupling of neural activity to the bold hemodynamic response. / Neuroimage, / 10, 6-4.
36. Damoiseaux, J. S., Beckmann, C. F., Arigita, E. J., Barkhof, F., Scheltens, P., Stam, C. J., et al. (2008). Reduced resting-state brain activity in the “default network-in normal aging. / Cerebral Cortex, / 18, 1856-864.
37. Daselaar, S. M., Fleck, M. S., Dobbins, I. G., Madden, D. J., & Cabeza, R. (2006). Effects of healthy aging on hippocampal and rhinal memory functions: An event-related fMRI study. / Cerebral Cortex, / 16(12), 1771-782.
38. Daselaar, S. M., Prince, S. E., & Cabeza, R. (2004). When less means more: Deactivations during encoding that predict subsequent memory. / Neuroimage, / 23, 921-27.
39. Daselaar, S. M., Veltman, D. J., Rombouts, S. A., Raaijmakers, J. G., & Jonker, C. (2003). Neuroanatomical correlates of episodic encoding and retrieval in young and elderly subjects. / Brain, / 126, 43-6.
40. Davis, T. L., Kwong, K. K., Weisskoff, R. M., & Rosen, B. R. (1998). Calibrated functional MRI: Mapping the dynamics of oxidative metabolism. / Proceedings of the National Academy of Sciences of the United States of America, / 95, 1834-839.
41. DeKosky, S. T., Ikonomovic, M. D., Styren, S. D., Beckett, L., Wisniewski, S., Bennett, D. A., et al. (2002). Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. / Annals of Neurology, / 51, 145-55.
42. DeKosky, S. T., & Marek, K. (2003). Looking backward to move forward: Early detection of neurodegenerative disorders. / Science, / 302, 830-34.
43. Dickerson, B. C., Miller, S. L., Greve, D. N., Dale, A. M., Albert, M. S., Schacter, D. L., et al. (2007a). Prefrontal-hippocampal-fusiform activity during encoding predicts intraindividual differences in free recall ability: An event-related functional-anatomic MRI study. / Hippocampus, / 17(11), 1060-070.
44. Dickerson, B. C., Salat, D. H., Bates, J. F., Atiya, M., Killiany, R. J., Greve, D. N., et al. (2004). Medial temporal lobe function and structure in mild cognitive impairment. / Annals of Neurology, / 56, 27-5.
45. Dickerson, B. C., Salat, D., Greve, D., Chua, E., Rand-Giovannetti, E., Rentz, D., et al. (2005). Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. / Neurology, / 65, 404-11.
46. Dickerson, B. C., & Sperling, R. A. (2005). Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer’s disease. / NeuroRx, / 2, 348-60.
47. Dickerson, B. C., & Sperling, R. A. (2008). Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer’s disease: Insights from functional MRI studies. / Neuropsychologia, / 46, 1624-635.
48. Dickerson, B. C., Sperling, R. A., Hyman, B. T., Albert, M. S., & Blacker, D. (2007b). Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. / Archives of General Psychiatry, / 64, 1443-450.
49. Dodart, J. C., Bales, K. R., Gannon, K. S., Greene, S. J., DeMattos, R. B., Mathis, C., et al. (2002). Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer’s disease model. / Nature Neuroscience, / 5, 452-57.
50. Dubois, B., Feldman, H. H., Jacova, C., Dekosky, S. T., Barberger-Gateau, P., Cummings, J., et al. (2007). Research criteria for the diagnosis of Alzheimer’s disease: Revising the NINCDS-ADRDA criteria. / Lancet Neurology, / 6, 734-46.
51. Eichenbaum, H., & Bunsey, M. (1995). On the binding of associations in memory: Clues from studies on the role of the hippocampal region in paired-associate learning. / Current Directions in Psychological Science, / 4, 19-3.
52. Eichenbaum, H., Schoenbaum, G., Young, B., & Bunsey, M. (1996). Functional organization of the hippocampal memory system. / Proceedings of the National Academy of Sciences of the United States of America, / 93, 13500-3507.
53. Fagan, A. M., Head, D., Shah, A. R., Marcus, D., Mintun, M., Morris, J. C., et al. (2009). Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly. / Annals of Neurology, / 65, 176-83.
54. Fagan, A. M., Mintun, M. A., Mach, R. H., Lee, S. Y., Dence, C. S., Shah, A. R., et al. (2006). Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. / Annals of Neurology, / 59, 512-19.
55. Filippini, N., MacIntosh, B. J., Hough, M. G., Goodwin, G. M., Frisoni, G. B., Smith, S. M., et al. (2009). Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. / Proceedings of the National Academy of Sciences of the United States of America, / 106, 7209-214.
56. Fleisher, A. S., Houston, W. S., Eyler, L. T., Frye, S., Jenkins, C., Thal, L. J., et al. (2005). Identification of Alzheimer disease risk by functional magnetic resonance imaging. / Archives of Neurology, / 62, 1881-888.
57. Fleisher, A. S., Sherzai, A., Taylor, C., Langbaum, J. B., Chen, K., & Buxton, R. B. (2009). Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer’s disease risk groups. / Neuroimage, / 47(4), 1678-690.
58. Fowler, K. S., Saling, M. M., Conway, E. L., Semple, J. M., & Louis, W. J. (2002). Paired associate performance in the early detection of DAT. / Journal of the International Neuropsychological Society, / 8, 58-1.
59. Gallo, D. A., Sullivan, A. L., Daffner, K. R., Schacter, D. L., & Budson, A. E. (2004). Associative recognition in Alzheimer’s disease: Evidence for impaired recall-to-reject. / Neuropsychology, / 18, 556-63.
60. Gilman, S., Koller, M., Black, R. S., Jenkins, L., Griffith, S. G., Fox, N. C., et al. (2005). Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. / Neurology, / 64, 1553-562.
61. Golby, A., Silverberg, G., Race, E., Gabrieli, S., O’Shea, J., Knierim, K., et al. (2005). Memory encoding in Alzheimer’s disease: An fMRI study of explicit and implicit memory. / Brain, / 128, 773-87.
62. Gomperts, S. N., Rentz, D. M., Moran, E., Becker, J. A., Locascio, J. J., Klunk, W. E., et al. (2008). Imaging amyloid deposition in Lewy body diseases. / Neurology, / 71, 903-10.
63. Grady, C. L., McIntosh, A. R., Beig, S., Keightley, M. L., Burian, H., & Black, S. E. (2003). Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer’s disease. / Journal of Neuroscience, / 23, 986-93.
64. Greicius, M. D., Krasnow, B., Reiss, A. L., & Menon, V. (2003). Functional connectivity in the resting brain: A network analysis of the default mode hypothesis. / Proceedings of the National Academy of Sciences of the United States of America, / 100, 253-58.
65. Greicius, M. D., Srivastava, G., Reiss, A. L., & Menon, V. (2004). Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: Evidence from functional MRI. / Proceedings of the National Academy of Sciences of the United States of America, / 101, 4637-642.
66. Gron, G., Bittner, D., Schmitz, B., Wunderlich, A. P., & Riepe, M. W. (2002). Subjective memory complaints: Objective neural markers in patients with Alzheimer’s disease and major depressive disorder. / Annals of Neurology, / 51, 491-98.
67. Grundman, M., et al. (2004). Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. / Archives of Neurology, / 61, 59-6.
68. Haier, R. J., Alkire, M. T., White, N. S., Uncapher, M. R., Head, E., Lott, I. T., et al. (2003). Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia. / Neurology, / 61, 1673-679.
69. Hamalainen, A., Pihlajamaki, M., Tanila, H., Hanninen, T., Niskanen, E., Tervo, S., et al. (2007). Increased fMRI responses during encoding in mild cognitive impairment. / Neurobiology of Aging, / 28, 1889-903.
70. Han, S. D., Houston, W. S., Jak, A. J., Eyler, L. T., Nagel, B. J., Fleisher, A. S., et al. (2007). Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. / Neurobiology of Aging, / 28, 238-47.
71. Hashimoto, M., & Masliah, E. (2003). Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer’s and dementia with Lewy bodies. / Neurochemical Research, / 28, 1743-756.
72. Hedden, T., Van Dijk, K., Becker, J. A., Mehta, A., Sperling, R. A., Johnson, K. A., et al. (2009). Disruption of default network functional connectivity in clinically normal older adults harboring amyloid burden. / Journal of Neuroscience, / 29(40), 12686-2694.
73. Heun, R., Freymann, K., Erb, M., Leube, D. T., Jessen, F., Kircher, T. T., et al. (2007). Mild cognitive impairment (MCI) and actual retrieval performance affect cerebral activation in the elderly. / Neurobiology of Aging, / 28, 404-13.
74. Hulette, C. M., Welsh-Bohmer, K. A., Murray, M. G., Saunders, A. M., Mash, D. C., & McIntyre, L. M. (1998). Neuropathological and neuropsychological changes in “normal-aging: Evidence for preclinical Alzheimer disease in cognitively normal individuals. / Journal of Neuropathology and Experimental Neurology, / 57, 1168-174.
75. Hyman, B. T., Marzloff, K., Wenniger, J. J., Dawson, T. M., Bredt, D. S., & Snyder, S. H. (1992). Relative sparing of nitric oxide synthase-containing neurons in the hippocampal formation in Alzheimer’s disease. / Annals of Neurology, / 32, 818-20.
76. Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984). Alzheimer’s disease: Cell-specific pathology isolates the hippocampal formation. / Science, / 225, 1168-170.
77. Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., et al. (2008). Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease. / Brain, / 131, 1630-645.
78. Ingelsson, M., Fukumoto, H., Newell, K. L., Growdon, J. H., Hedley-Whyte, E. T., Frosch, M. P., et al. (2004). Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. / Neurology, / 62, 925-31.
79. Jack, C. R, Jr., Lowe, V. J., Senjem, M. L., Weigand, S. D., Kemp, B. J., Shiung, M. M., et al. (2008). 11C PiB and structural MRI provide complementary information in imaging of Alzheimer’s disease and amnestic mild cognitive impairment. / Brain, / 131, 665-80.
80. Jack, C. R, Jr., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., et al. (2009). Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: Implications for sequence of pathological events in Alzheimer’s disease. / Brain, / 132, 1355-365.
81. Jagust, W., Gitcho, A., Sun, F., Kuczynski, B., Mungas, D., & Haan, M. (2006). Brain imaging evidence of preclinical Alzheimer’s disease in normal aging. / Annals of Neurology, / 59, 673-81.
82. Johnson, S. C., Baxter, L. C., Susskind-Wilder, L., Connor, D. J., Sabbagh, M. N., & Caselli, R. J. (2004). Hippocampal adaptation to face repetition in healthy elderly and mild cognitive impairment. / Neuropsychologia, / 42, 980-89.
83. Johnson, K. A., Gregas, M., Becker, J. A., Kinnecom, C., Salat, D. H., Moran, E. K., et al. (2007). Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. / Annals of Neurology, / 62, 229-34.
84. Johnson, S. C., Schmitz, T. W., Moritz, C. H., Meyerand, M. E., Rowley, H. A., Alexander, A. L., et al. (2006a). Activation of brain regions vulnerable to Alzheimer’s disease: The effect of mild cognitive impairment. / Neurobiology of Aging, / 27, 1604-612.
85. Johnson, S. C., Schmitz, T. W., Trivedi, M. A., Ries, M. L., Torgerson, B. M., Carlsson, C. M., et al. (2006b). The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. / Journal of Neuroscience, / 26, 6069-076.
86. Kahn, I., Andrews-Hanna, J. R., Vincent, J. L., Snyder, A. Z., & Buckner, R. L. (2008). Distinct cortical anatomy linked to subregions of the medial temporal lobe revealed by intrinsic functional connectivity. / Journal of Neurophysiology, / 100(1), 129-39.
87. Kato, T., Knopman, D., & Liu, H. (2001). Dissociation of regional activation in mild AD during visual encoding: A functional MRI study. / Neurology, / 57, 812-16.
88. Katzman, R. (1997). The aging brain. Limitations in our knowledge and future approaches. / Archives of Neurology, / 54, 1201-205.
89. Kircher, T., Weis, S., Freymann, K., Erb, M., Jessen, F., Grodd, W., et al. (2007). Hippocampal activation in MCI patients is necessary for successful memory encoding. / Journal of Neurology, Neurosurgery and Psychiatry, / 78(8), 812-18.
90. Kirwan, C. B., & Stark, C. E. (2004). Medial temporal lobe activation during encoding and retrieval of novel face-name pairs. / Hippocampus, / 14, 919-30.
91. Klein, W. L. (2006). Synaptic targeting by A-beta oligomers (ADDLS) as a basis for memory loss in early Alzheimer’s disease. / Alzheimer’s & Dementia, / 2, 43-5.
92. Klunk, W. E., et al. (2004). Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B. / Annals of Neurology, / 55, 306-19.
93. Klyubin, I., Walsh, D. M., Lemere, C. A., Cullen, W. K., Shankar, G. M., Betts, V., et al. (2005). Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. / Nature Medicine, / 11, 556-61.
94. Kobayashi, Y., & Amaral, D. G. (2007). Macaque monkey retrosplenial cortex: III. Cortical efferents. / Journal of Comparative Neurology, / 502, 810-33.
95. Kwong, K. K., Belliveau, J. W., Chesler, D. A., Goldberg, I. E., Weisskoff, R. M., Poncelet, B. P., et al. (1992). Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. / Proceedings of the National Academy of Sciences of the United States of America, / 89, 5675-679.
96. Leirer, V. O., Morrow, D. G., Sheikh, J. I., & Pariante, G. M. (1990). Memory skills elders want to improve. / Experimental Aging Research, / 16, 155-58.
97. Lesne, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., et al. (2006). A specific amyloid-beta protein assembly in the brain impairs memory. / Nature, / 440, 352-57.
98. Lind, J., Ingvar, M., Persson, J., Sleegers, K., Van Broeckhoven, C., Adolfsson, R., et al. (2006a). Parietal cortex activation predicts memory decline in apolipoprotein E-epsilon4 carriers. / Neuroreport, / 17, 1683-686.
99. Lind, J., Larsson, A., Persson, J., Ingvar, M., Nilsson, L. G., Backman, L., et al. (2006b). Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: Relation to chronological age and recognition memory. / Neuroscience Letters, / 396, 23-7.
100. Logothetis, N. K., Pauls, J., Augath, M., Trinath, T., & Oeltermann, A. (2001). Neurophysiological investigation of the basis of the fMRI signal. / Nature, / 412, 150-57.
101. Lopresti, B. J., Klunk, W. E., Mathis, C. A., Hoge, J. A., Ziolko, S. K., Lu, X., et al. (2005). Simplified quantification of Pittsburgh compound B amyloid imaging PET studies: A comparative analysis. / Journal of Nuclear Medicine, / 46, 1959-972.
102. Lustig, C., & Buckner, R. L. (2004). Preserved neural correlates of priming in old age and dementia. / Neuron, / 42, 865-75.
103. Lustig, C., Snyder, A. Z., Bhakta, M., O’Brien, K. C., McAvoy, M., Raichle, M. E., et al. (2003). Functional deactivations: Change with age and dementia of the Alzheimer type. / Proceedings of the National Academy of Sciences of the United States of America, / 100, 14504-4509.
104. Machielsen, W. C., Rombouts, S. A., Barkhof, F., Scheltens, P., & Witter, M. P. (2000). FMRI of visual encoding: Reproducibility of activation. / Human Brain Mapping, / 9, 156-64.
105. Machulda, M. M., Ward, H. A., Borowski, B., Gunter, J. L., Cha, R. H., O’Brien, P. C., et al. (2003). Comparison of memory fMRI response among normal, MCI, and Alzheimer’s patients. / Neurology, / 61, 500-06.
106. Manoach, D. S., Halpern, E. F., Kramer, T. S., Chang, Y., Goff, D. C., Rauch, S. L., et al. (2001). Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjects. / American Journal of Psychiatry, / 158, 955-58.
107. Markesbery, W. R., Schmitt, F. A., Kryscio, R. J., Davis, D. G., Smith, C. D., & Wekstein, D. R. (2006). Neuropathologic substrate of mild cognitive impairment. / Archives of Neurology, / 63, 38-6.
108. Mathis, C. A., Price, J., McNamee, R. L., Redfield, A. S., Berginc, M., Klunk, W. E., et al. (2008). Initial report of ADNI PIB-PET imaging studies. In / Human Amyloid Imaging, Chicago, Illinois.
109. Mathis, C. A., Wang, Y., Holt, D. P., Huang, G. F., Debnath, M. L., & Klunk, W. E. (2003). Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. / Journal of Medicinal Chemistry, / 46, 2740-754.
110. Meguro, K., LeMestric, C., Landeau, B., Desgranges, B., Eustache, F., & Baron, J. C. (2001). Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer’s disease: A PET/MRI correlative study. / Journal of Neurology, Neurosurgery and Psychiatry, / 71, 315-21.
111. Meltzer, C. C., Zubieta, J. K., Brandt, J., Tune, L. E., Mayberg, H. S., & Frost, J. J. (1996). Regional hypometabolism in Alzheimer’s disease as measured by positron emission tomography after correction for effects of partial volume averaging. / Neurology, / 47, 454-61.
112. Mesulam, M. M. (1990). Large-scale neurocognitive networks and distributed processing for attention, language, and memory. / Annals of Neurology, / 28, 597-13.
113. Mesulam, M. M. (1998). From sensation to cognition. / Brain, / 121(Pt 6), 1013-052.
114. Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., et al. (2008). Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease. / Nature, / 451, 720-24.
115. Miller, S. L., Celone, K., DePeau, K., Diamond, E., Dickerson, B. C., Rentz, D., et al. (2008a). Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation. / Proceedings of the National Academy of Sciences of the United States of America, / 105, 2181-186.
116. Miller, S. L., Fenstermacher, E., Bates, J., Blacker, D., Sperling, R. A., & Dickerson, B. C. (2008b). Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline. / Journal of Neurology, Neurosurgery and Psychiatry, / 79, 630-35.
117. Mintun, M. A., Larossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., et al. (2006). [11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease. / Neurology, / 67, 446-52.
118. Mintun, M. A., Vlassenko, A., Sacco, D., LaRossa, G. N., Sheline, Y. I., Mach, R. H., et al. (2008) Patterns of 11C PIB uptake in non-demented subjects. In / Human Amyloid Imaging, Chicago, Ilinois.
119. Mondadori, C. R., Buchmann, A., Mustovic, H., Schmidt, C. F., Boesiger, P., Nitsch, R. M., et al. (2006). Enhanced brain activity may precede the diagnosis of Alzheimer’s disease by 30?years. / Brain, / 129, 2908-922.
120. Mondadori, C. R., de Quervain, D. J., Buchmann, A., Mustovic, H., Wollmer, M. A., Schmidt, C. F., et al. (2007). Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. / Cerebral Cortex, / 17, 1934-947.
121. Morcom, A. M., & Fletcher, P. C. (2007). Does the brain have a baseline? Why we should be resisting a rest. / Neuroimage, / 37, 1073-082.
122. Mormino, E. C., Kluth, J. T., Madison, C. M., Rabinovici, G. D., Baker, S. L., Miller, B. L., et al. (2008). Episodic memory loss is related to hippocampal-mediated {beta}-amyloid deposition in elderly subjects. / Brain, / 132(Pt 5), 1310-323.
123. Morris, J. C., & Cummings, J. (2005). Mild cognitive impairment (MCI) represents early-stage Alzheimer’s disease. / Journal of Alzheimer’s Disease, / 7, 235-39. discussion 255-262.
124. Morris, J. C., McKeel, D. W, Jr., Storandt, M., Rubin, E. H., Price, J. L., Grant, E. A., et al. (1991). Very mild Alzheimer’s disease: Informant-based clinical, psychometric, and pathologic distinction from normal aging. / Neurology, / 41, 469-78.
125. Morris, J. C., Storandt, M., McKeel, D. W, Jr., Rubin, E. H., Price, J. L., Grant, E. A., et al. (1996). Cerebral amyloid deposition and diffuse plaques in “normal-aging: Evidence for presymptomatic and very mild Alzheimer’s disease. / Neurology, / 46, 707-19.
126. Oddo, S., Caccamo, A., Tran, L., Lambert, M. P., Glabe, C. G., Klein, W. L., et al. (2006). Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. / J Biol Chem, / 281, 1599-604.
127. Ogawa, S., Lee, T. M., Nayak, A. S., & Glynn, P. (1990). Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. / Magnetic Resonance in Medicine, / 14, 68-8.
128. Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., et al. (2007). Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease. / Neuron, / 55, 697-11.
129. Pariente, J., Cole, S., Henson, R., Clare, L., Kennedy, A., Rossor, M., et al. (2005). Alzheimer’s patients engage an alternative network during a memory task. / Annals of Neurology, / 58, 870-79.
130. Persson, J., Lind, J., Larsson, A., Ingvar, M., Sleegers, K., Van Broeckhoven, C., et al. (2008). Altered deactivation in individuals with genetic risk for Alzheimer’s disease. / Neuropsychologia, / 46, 1679-687.
131. Petersen, R. C., Parisi, J. E., Dickson, D. W., Johnson, K. A., Knopman, D. S., Boeve, B. F., et al. (2006). Neuropathologic features of amnestic mild cognitive impairment. / Archives of Neurology, / 63, 665-72.
132. Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: Clinical characterization and outcome. / Archives of Neurology, / 56, 303-08.
133. Petrella, J. R., Krishnan, S., Slavin, M. J., Tran, T. T., Murty, L., & Doraiswamy, P. M. (2006). Mild cognitive impairment: Evaluation with 4-T functional MR imaging. / Radiology, / 240, 177-86.
134. Petrella, J. R., Prince, S. E., Wang, L., Hellegers, C., & Doraiswamy, P. M. (2007). Prognostic value of posteromedial cortex deactivation in mild cognitive impairment. / PLoS ONE, / 2, e1104.
135. Pihlajamaki, M., Depeau, K. M., Blacker, D., & Sperling, R. A. (2008). Impaired medial temporal repetition suppression is related to failure of parietal deactivation in Alzheimer disease. / American Journal of Geriatric Psychiatry, / 16, 283-92.
136. Pihlajamaki, M., O’Keefe, K., Bertram, L., Tanzi, R., Dickerson, B., Blacker, D., et al. (2009). Evidence of altered posteromedial cortical fMRI activity in subjects at risk for Alzheimer disease. / Alzheimer Disease and Associated Disorders (e-pub).
137. Pike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., et al. (2007). Beta-amyloid imaging and memory in non-demented individuals: Evidence for preclinical Alzheimer’s disease. / Brain, / 130, 2837-844.
138. Price, C. J., & Friston, K. J. (1999). Scanning patients with tasks they can perform. / Human Brain Mapping, / 8, 102-08.
139. Price, J. L., & Morris, J. C. (1999). Tangles and plaques in nondemented aging and “preclinical-Alzheimer’s disease. / Annals of Neurology, / 45, 358-68.
140. Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001). A default mode of brain function. / Proceedings of the National Academy of Sciences of the United States of America, / 98, 676-82.
141. Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., et al. (2004). Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia. / Proceedings of the National Academy of Sciences of the United States of America, / 101, 284-89.
142. Remy, F., Mirrashed, F., Campbell, B., & Richter, W. (2004). Mental calculation impairment in Alzheimer’s disease: A functional magnetic resonance imaging study. / Neuroscience Letters, / 358, 25-8.
143. Remy, F., Mirrashed, F., Campbell, B., & Richter, W. (2005). Verbal episodic memory impairment in Alzheimer’s disease: A combined structural and functional MRI study. / Neuroimage, / 25, 253-66.
144. Rentz, D. M., Sardinha, L. M., Manning, L. N., Moran, E. K., Becker, J. A., DeKosky, S. T., et al. (2006). Amyloid burden correlates with cognitive function in normal aging, MCI and AD. In / Alzheimer Imaging Consortium, International Conference on Alzheimer’s Disease. Madrid, Spain.
145. Rombouts, S. A., Barkhof, F., Goekoop, R., Stam, C. J., & Scheltens, P. (2005a). Altered resting state networks in mild cognitive impairment and mild Alzheimer’s disease: An fMRI study. / Human Brain Mapping, / 26, 231-39.
146. Rombouts, S. A., Barkhof, F., Veltman, D. J., Machielsen, W. C., Witter, M. P., Bierlaagh, M. A., et al. (2000). Functional MR imaging in Alzheimer’s disease during memory encoding. / AJNR. American Journal of Neuroradiology, / 21, 1869-875.
147. Rombouts, S. A., Damoiseaux, J. S., Goekoop, R., Barkhof, F., Scheltens, P., Smith, S. M., et al. (2009). Model-free group analysis shows altered BOLD FMRI networks in dementia. / Human Brain Mapping, / 30, 256-66.
148. Rombouts, S. A., Goekoop, R., Stam, C. J., Barkhof, F., & Scheltens, P. (2005b). Delayed rather than decreased BOLD response as a marker for early Alzheimer’s disease. / Neuroimage, / 26, 1078-085.
149. Schwindt, G. C., & Black, S. E. (2009). Functional imaging studies of episodic memory in Alzheimer’s disease: A quantitative meta-analysis. / Neuroimage, / 45, 181-90.
150. Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009). Neurodegenerative diseases target large-scale human brain networks. / Neuron, / 62, 42-2.
151. Selkoe, D. J. (2002). Alzheimer’s disease is a synaptic failure. / Science, / 298, 789-91.
152. Sheth, S. A., Nemoto, M., Guiou, M., Walker, M., Pouratian, N., & Toga, A. W. (2004). Linear and nonlinear relationships between neuronal activity, oxygen metabolism, and hemodynamic responses. / Neuron, / 42, 347-55.
153. Shmuel, A., Augath, M., Oeltermann, A., & Logothetis, N. K. (2006). Negative functional MRI response correlates with decreases in neuronal activity in monkey visual area V1. / Nature Neuroscience, / 9, 569-77.
154. Shulman, G. L., Fiez, J. A., Corbetta, M., Buckner, R. L., Miezin, F. M., Raichle, M. E., et al. (1997). Common blood flow changes across visual tasks: Decreases in cerebral cortex. / Journal of Cognitive Neuroscience, / 9, 648-63.
155. Silverman, D. H., et al. (2001). Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. / JAMA, / 286, 2120-127.
156. Small, G. W., Ercoli, L. M., Silverman, D. H., Huang, S. C., Komo, S., Bookheimer, S. Y., et al. (2000). Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease. / Proceedings of the National Academy of Sciences of the United States of America, / 97, 6037-042.
157. Small, S. A., Nava, A. S., Perera, G. M., DeLaPaz, R., Mayeux, R., & Stern, Y. (2001). Circuit mechanisms underlying memory encoding and retrieval in the long axis of the hippocampal formation. / Nature Neuroscience, / 4, 442-49.
158. Small, S. A., Perera, G. M., DeLaPaz, R., Mayeux, R., & Stern, Y. (1999). Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer’s disease. / Annals of Neurology, / 45, 466-72.
159. Smith, C. D., Andersen, A. H., Kryscio, R. J., Schmitt, F. A., Kindy, M. S., Blonder, L. X., et al. (1999). Altered brain activation in cognitively intact individuals at high risk for Alzheimer’s disease. / Neurology, / 53, 1391-396.
160. Smith, C. D., Andersen, A. H., Kryscio, R. J., Schmitt, F. A., Kindy, M. S., Blonder, L. X., et al. (2002). Women at risk for AD show increased parietal activation during a fluency task. / Neurology, / 58, 1197-202.
161. Smith, C. D., Chebrolu, H., Wekstein, D. R., Schmitt, F. A., Jicha, G. A., Cooper, G., et al. (2007). Brain structural alterations before mild cognitive impairment. / Neurology, / 68, 1268-273.
162. Sorg, C., Riedl, V., Muhlau, M., Calhoun, V. D., Eichele, T., Laer, L., et al. (2007). Selective changes of resting-state networks in individuals at risk for Alzheimer’s disease. / Proceedings of the National Academy of Sciences of the United States of America, / 104, 18760-8765.
163. Sperling, R. (2007). Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer’s disease. / Annals of the New York Academy of Sciences, / 1097, 146-55.
164. Sperling, R. A., Bates, J. F., Chua, E. F., Cocchiarella, A. J., Rentz, D. M., Rosen, B. R., et al. (2003a). fMRI studies of associative encoding in young and elderly controls and mild Alzheimer’s disease. / Journal of Neurology, Neurosurgery and Psychiatry, / 74, 44-0.
165. Sperling, R. A., Bates, J., Cocchiarella, A., Schacter, D., Rosen, B., & Albert, M. (2001). Encoding Novel Face-Name Associations: A Functional MRI Study. / Human Brain Mapping, / 14, 129-39.
166. Sperling, R., Chua, E., Cocchiarella, A., Rand-Giovannetti, E., Poldrack, R., Schacter, D. L., et al. (2003b). Putting names to faces: Successful encoding of associative memories activates the anterior hippocampal formation. / Neuroimage, / 20, 1400-410.
167. Sperling, R., Greve, D., Dale, A., Killiany, R., Holmes, J., Rosas, H. D., et al. (2002). Functional MRI detection of pharmacologically induced memory impairment. / Proceedings of the National Academy of Sciences of the United States of America, / 99, 455-60.
168. Sperling, R. A., Laviolette, P., O’Keefe, K., O’Brien, J., Rentz, D., Pihlajamaki, M., et al. (2009). Amyloid deposition is associated with impaired default network function in older persons without dementia. / Neuron, / 63(2), 178-88.
169. Sperling, R. A., O’Brien, J., O’Keefe, K., DeLuca, A., LaViolette, P., Bakkour, A., et al. (2008). Longitudinal fMRI demonstrates loss of hippocampal activation over the course of MCI. / Neurology, / 70, A445.
170. Spires, T. L., & Hyman, B. T. (2004). Neuronal structure is altered by amyloid plaques. / Reviews in the Neurosciences, / 15, 267-78.
171. Spires, T. L., Meyer-Luehmann, M., Stern, E. A., McLean, P. J., Skoch, J., Nguyen, P. T., et al. (2005). Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. / Journal of Neuroscience, / 25, 7278-287.
172. Squire, L. R., & Zola-Morgan, S. (1991). The medial temporal lobe memory system. / Science, / 253, 1380-386.
173. Stern, Y. (2006). Cognitive reserve and Alzheimer disease. / Alzheimer Disease and Associated Disorders, / 20, 112-17.
174. Stern, E. A., Bacskai, B. J., Hickey, G. A., Attenello, F. J., Lombardo, J. A., & Hyman, B. T. (2004). Cortical synaptic integration in vivo is disrupted by amyloid-beta plaques. / Journal of Neuroscience, / 24, 4535-540.
175. Svoboda, E., McKinnon, M. C., & Levine, B. (2006). The functional neuroanatomy of autobiographical memory: A meta-analysis. / Neuropsychologia, / 44, 2189-208.
176. Thompson, J. K., Peterson, M. R., & Freeman, R. D. (2003). Single-neuron activity and tissue oxygenation in the cerebral cortex. / Science, / 299, 1070-072.
177. Tomlinson, B. E., Blessed, G., & Roth, M. (1970). Observations on the brains of demented old people. / Journal of the Neurological Sciences, / 11, 205-42.
178. Trivedi, M. A., Schmitz, T. W., Ries, M. L., Torgerson, B. M., Sager, M. A., Hermann, B. P., et al. (2006). Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer’s disease: A cross-sectional study. / BMC Medicine, / 4, 1.
179. Vannini, P., O’Brien, J., Putcha, D., O’Keefe, K., Pihlajamaki, M., LaViolette, P., et al. (2009). Successful memory retrieval requires increased parietal activity in asymptomatic older adults with high amyloid burden. In / International Conference on Alzheimer’s Disease. Vienna, Austria.
180. Vincent, J. L., Patel, G. H., Fox, M. D., Snyder, A. Z., Baker, J. T., Van Essen, D. C., et al. (2007). Intrinsic functional architecture in the anaesthetized monkey brain. / Nature, / 447, 83-6.
181. Vincent, J. L., Snyder, A. Z., Fox, M. D., Shannon, B. J., Andrews, J. R., Raichle, M. E., et al. (2006). Coherent spontaneous activity identifies a hippocampal-parietal memory network. / Journal of Neurophysiology, / 96, 3517-531.
182. Wagner, A. D., Schacter, D. L., Rotte, M., Koutstaal, W., Maril, A., Dale, A. M., et al. (1998). Building memories: Remembering and forgetting of verbal experiences as predicted by brain activity. / Science, / 281, 1188-191.
183. Wagner, A. D., Shannon, B. J., Kahn, I., & Buckner, R. L. (2005). Parietal lobe contributions to episodic memory retrieval. / Trends in Cognitive Sciences, / 9, 445-53.
184. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., et al. (2002). Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. / Nature, / 416, 535-39.
185. Walsh, D. M., & Selkoe, D. J. (2004). Deciphering the molecular basis of memory failure in Alzheimer’s disease. / Neuron, / 44, 181-93.
186. Weksler, M. E., Gouras, G., Relkin, N. R., & Szabo, P. (2005). The immune system, amyloid-beta peptide, and Alzheimer’s disease. / Immunological Reviews, / 205, 244-56.
187. Whitwell, J. L., Shiung, M. M., Przybelski, S. A., Weigand, S. D., Knopman, D. S., Boeve, B. F., et al. (2007). MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. / Neurology, / 70(7), 512-20.
188. Wierenga, C. E., & Bondi, M. W. (2007). Use of functional magnetic resonance imaging in the early identification of Alzheimer’s disease. / Neuropsychology Review, / 17, 127-43.
189. Wishart, H. A., Saykin, A. J., McDonald, B. C., Mamourian, A. C., Flashman, L. A., Schuschu, K. R., et al. (2004). Brain activation patterns associated with working memory in relapsing-remitting MS. / Neurology, / 62, 234-38.
190. Zeineh, M. M., Engel, S. A., Thompson, P. M., & Bookheimer, S. Y. (2003). Dynamics of the hippocampus during encoding and retrieval of face-name pairs. / Science, / 299, 577-80.
191. Zelinski, E. M., & Gilewski, M. J. (1988). Assessment of memory complaints by rating scales and questionnaires. / Psychopharmacology Bulletin, / 24, 523-29. - 作者单位：Reisa A. Sperling (1) (2) (4) (5)
Bradford C. Dickerson (2) (4) (5)
Maija Pihlajamaki (1) (5)
Patrizia Vannini (1) (4) (5)
Peter S. LaViolette (1) (4)
Ottavio V. Vitolo (1) (5)
Trey Hedden (3) (4)
J. Alex Becker (3)
Dorene M. Rentz (1) (5)
Dennis J. Selkoe (1) (5)
Keith A. Johnson (1) (3) (5)
1. Department of Neurology, Center for Alzheimer’s Research and Treatment, Brigham and Women’s Hospital, 221 Longwood Avenue, Boston, MA, 02115, USA
2. Department of Neurology, Massachusetts General Hospital, Boston, MA, USA
4. The Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, MA, USA
5. Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA
3. Department of Radiology, Massachusetts General Hospital, Boston, MA, USA
文摘
The hallmark clinical symptom of early Alzheimer’s disease (AD) is episodic memory impairment. Recent functional imaging studies suggest that memory function is subserved by a set of distributed networks, which include both the medial temporal lobe (MTL) system and the set of cortical regions collectively referred to as the default network. Specific regions of the default network, in particular, the posteromedial cortices, including the precuneus and posterior cingulate, are selectively vulnerable to early amyloid deposition in AD. These regions are also thought to play a key role in both memory encoding and retrieval, and are strongly functionally connected to the MTL. Multiple functional magnetic resonance imaging (fMRI) studies during memory tasks have revealed alterations in these networks in patients with clinical AD. Similar functional abnormalities have been detected in subjects at-risk for AD, including those with genetic risk and older individuals with mild cognitive impairment. Recently, we and other groups have found evidence of functional alterations in these memory networks even among cognitively intact older individuals with occult amyloid pathology, detected by PET amyloid imaging. Taken together, these findings suggest that the pathophysiological process of AD exerts specific deleterious effects on these distributed memory circuits, even prior to clinical manifestations of significant memory impairment. Interestingly, some of the functional alterations seen in prodromal AD subjects have taken the form of increases in activity relative to baseline, rather than a loss of activity. It remains unclear whether these increases in fMRI activity may be compensatory to maintain memory performance in the setting of early AD pathology or instead, represent evidence of excitotoxicity and impending neuronal failure. Recent studies have also revealed disruption of the intrinsic connectivity of these networks observable even during the resting state in early AD and asymptomatic individuals with high amyloid burden. Research is ongoing to determine if these early network alterations will serve as sensitive predictors of clinical decline, and eventually, as markers of pharmacological response to potential disease-modifying treatments for AD.